èªç¥çã±ã¢ã«é¢ããèªé²ãŸãšã
èªç¥çã±ã¢ã«æºããäžã§ããã®æå³ãæ代èæ¯ãªã©æ§ã ãªå 容ãç解ããŠããéã«ã©ã®ãããªè¡šèšã§ãç解ã§ããããã«åããããããããã®æ代ãå°éè·ããäžè¬ã®å人ãŸã§åãéãŠãªããã®å 容ãç解ã§ããæ代ãžãšçµã³ã€ããããšæãã
èªé²
MCI ïŒè»œåºŠèªç¥çïŒããããããããããããBPSD ïŒè¡åã»å¿ççç¶ïŒ
DSM-5 ïŒç²Ÿç¥é害蚺æçµ±èšããã¥ã¢ã«ïŒãããHDS-R ïŒæ¹èšé·è°·å·åŒç°¡æç¥èœè©äŸ¡ã¹ã±ãŒã«ïŒ
MMSE ïŒããã¡ã³ã¿ã«ã¹ããŒãæ€æ»ïŒããããCDR ïŒèšåºèªç¥çè©äŸ¡æ³ïŒ
FAST ïŒfunctional assessment staging ã¢ã«ããã€ããŒåèªç¥çã®çç¶ã¹ããŒãžãç掻æ©èœã®é¢ããïŒæ®µéã«åé¡ãã芳å¯åŒã®è©äŸ¡å°ºåºŠïŒ
IADL ïŒæ段çæ¥åžžç掻åäœèœåïŒããããããADL ïŒæ¥åžžç掻åäœïŒ
SPECT ïŒè³ã®è¡æµã®æ€æ»ïŒãããããããããQOL (ã¯ãªãªãã£ãŒãªãã©ã€ãã»ç掻ã®è³ªïŒ
N-ADLæ€æ»ïŒæ¥åžžç掻åäœèœåè©äŸ¡å°ºåºŠïŒ COPDïŒæ ¢æ§éå¡æ§èºçŸæ£ïŒ
JCSïŒãžã£ãã³ã³ãŒãã¹ã±ãŒã«ã»æèé害ã®æ·±åºŠåé¡ïŒ
CPR ïŒå¿èºèçæ³ïŒããããããããããããICF ïŒåœéç掻æ©èœåé¡ïŒããããããããããã
ROãïŒãªã¢ãªãã£ãŒãªãªãšã³ããŒã·ã§ã³ïŒ
PEAPæ¥æ¬çãïŒèªç¥çã±ã¢ã«é©ããç°å¢ãæŽåããããã®æéïŒ
NPO ïŒç¹å®éå¶å©æŽ»åæ³äººïŒ
AD ïŒã¢ã«ããã€ããŒåèªç¥çïŒ
ãšããã³ã¹ãïŒèšŒæ ïŒãããããããããããã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ãïŒå»åž«ãšæ£è ãšã®ååãªæ å ±ãåŸãäžã§ã®åæïŒ
ãã€ã¹ããïŒçäŸïŒããããããããããããã¢ã»ã¹ã¡ã³ããïŒè©äŸ¡ã»æ»å®ïŒ
ã¡ãã£ã¹ã³ãïŒè¬ïŒããããããããããããããŒãã«ã³ãã¥ãã±ãŒã·ã§ã³ïŒèšèªïŒ
ãã©ãã£ããïŒèªãïŒããããããããããããã³ããŒãã«ã³ãã¥ãã±ãŒã·ã§ã³ïŒéèšèªïŒ
ã«ã³ãã¡ã¬ã³ã¹ãïŒäŒè°ã»åè°ïŒããããããã±ã¢ïŒä»è·ã»äžè©±ïŒ
ãã¡ãªã¹ã¿ã·ã¹ãïŒæåžžæ§ç¶æïŒããããããããªããŒã·ã§ã³ãïŒææ ãåãããããæ¬äººã®è©±ãåŠå®ããã«è³ãåŸããïŒ
ã³ã¿ãŒã«çå矀ïŒå¿æ°åŠæ³ãé節ã«ãªãèªåã®è³ãå èã溶ããŠãªããªã£ããšæãããšïŒ
ã«ãã°ã©çå矀ïŒäººç©èª€èªçå矀ïŒ
å«åŠ¬åŠæ³ãïŒè¢«å®³åŠæ³ã®äžã€ïŒ
èæ¯å åãïŒç°å¢å åã»å人å åïŒãããããç°å¢å åïŒå人çç°å¢ã»ç€ŸäŒçç°å¢ïŒ
åŸåŸè¡åãïŒå€ååã»ç®çå¿ååã»å®äœäžèœåïŒ
ç©ççç°å¢ãïŒå»ºç©ã»èšåã»ç©ºéïŒããããã瀟äŒçç°å¢ãïŒä»è·è ã®é¢ããæ¹ãæèã»åšå²ã®äººã®æ 床ãªã©ïŒ
éå¶çç°å¢ãïŒæœèšã®éå¶æ¹éã»ããã°ã©ã ïŒ
ãã£ãã·ã§ã³è©äŸ¡æ³ãïŒç°å¢è©äŸ¡ææ³ïŒ
äžéãåèæžããæç²ããŠäžèšã«ãŸãšããŠèŠãŸãããããããèšèã®éããªã©ã«ããç解ã®äœæžãç®æãããŸãåŸã ã«ã¯æŽæ°ããŠè¡ããããšæããŸãã